Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 11 studies | 45% ± 21% | |
| GABAergic neuron | 9 studies | 43% ± 20% | |
| neuron | 6 studies | 27% ± 8% | |
| interneuron | 6 studies | 44% ± 18% | |
| retinal ganglion cell | 6 studies | 36% ± 15% | |
| Mueller cell | 5 studies | 28% ± 6% | |
| granule cell | 4 studies | 41% ± 11% | |
| GABAergic interneuron | 3 studies | 35% ± 3% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 36% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 95% | 3037.65 | 2520 / 2642 | 73% | 6.63 | 518 / 705 |
| prostate | 89% | 967.31 | 219 / 245 | 37% | 0.88 | 188 / 502 |
| uterus | 62% | 592.91 | 105 / 170 | 4% | 0.45 | 19 / 459 |
| adrenal gland | 7% | 27.67 | 19 / 258 | 50% | 6.02 | 116 / 230 |
| intestine | 14% | 43.98 | 135 / 966 | 1% | 0.01 | 3 / 527 |
| muscle | 9% | 30.15 | 72 / 803 | 0% | 0 | 0 / 0 |
| breast | 5% | 16.08 | 24 / 459 | 2% | 0.65 | 18 / 1118 |
| bladder | 5% | 27.57 | 1 / 21 | 2% | 0.07 | 10 / 504 |
| liver | 0% | 0 | 0 / 226 | 6% | 0.35 | 26 / 406 |
| skin | 3% | 6.73 | 51 / 1809 | 3% | 0.14 | 12 / 472 |
| blood vessel | 3% | 11.17 | 41 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 2% | 3.57 | 6 / 359 | 1% | 0.01 | 3 / 286 |
| lung | 0% | 0.47 | 1 / 578 | 3% | 0.08 | 29 / 1155 |
| kidney | 0% | 0 | 0 / 89 | 3% | 0.05 | 24 / 901 |
| esophagus | 0% | 0.13 | 1 / 1445 | 2% | 0.09 | 3 / 183 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
| pancreas | 0% | 0 | 0 / 328 | 1% | 0.06 | 2 / 178 |
| ovary | 1% | 0.98 | 1 / 180 | 0% | 0.00 | 1 / 430 |
| heart | 0% | 0.66 | 3 / 861 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0.39 | 2 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007040 | Biological process | lysosome organization |
| GO_0032588 | Cellular component | trans-Golgi network membrane |
| GO_0005802 | Cellular component | trans-Golgi network |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0005768 | Cellular component | endosome |
| GO_0030136 | Cellular component | clathrin-coated vesicle |
| GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
| GO_1902936 | Molecular function | phosphatidylinositol bisphosphate binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CLVS2 |
| Protein name | Clavesin-2 (Retinaldehyde-binding protein 1-like 2) (clathrin vesicle-associated Sec14 protein 2) |
| Synonyms | RLBP1L2 C6orf213 C6orf212 |
| Description | FUNCTION: Required for normal morphology of late endosomes and/or lysosomes in neurons (By similarity). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). . |
| Accessions | ENST00000275162.10 [Q5SYC1-1] Q5SYC1 ENST00000368438.1 [Q5SYC1-2] |
